Juan A. Arnaiz

Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive

Role: lead

Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine

Role: lead

Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels

Role: lead

Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.

Role: lead

Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

Role: lead

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

Role: lead

Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding

Role: lead

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

Role: lead

Intermittent ART in Primary HIV Infection

Role: lead

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

Role: lead

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Role: lead

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Role: lead

ARIpiprazole in Anorexia NErvosa

Role: lead

Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.

Role: lead

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

Role: lead

A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection

Role: lead

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

Role: lead

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature

Role: lead